Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro

Mediators of Inflammation

Volumn 13, Issue 5-6, 2004, Pages 313-319

  Kanai, Ken Ichi ^a   Asano, Kazuhito ^a   Hisamitsu, Tadashi ^a   Suzaki, Harumi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Macrolide antibiotic; Matrix metalloproteinase 9; Neutrophil; Roxithromycin; Suppression

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; ROXITHROMYCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ADULT; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOCONCENTRATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SUPERNATANT;

ANTI-BACTERIAL AGENTS; CELL MOVEMENT; GENE EXPRESSION; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 9; NEUTROPHILS; NF-KAPPA B; RNA, MESSENGER; ROXITHROMYCIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION FACTOR AP-1;

EID: 10944256351     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350400008810     Document Type: Article

References (34)

1. Iino Y, Toriyama M, Kudo K, Narita Y, Yuo A. Erythromycin inhibition of lipopolisaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Ann Otol Rhinol Laryngol 1992; 101(Suppl 157): 16-20.
2. Kadota J, Sakito O, Kohno S, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 147: 153-159.
3. Keicho N, Kudoh S. Diffuse panbronchiolitis - role of macrolides in therapy. Am J Respir Med 2002; 1: 119-131.
4. Jaffe A, Francis J, Rosenthal M, Bush A. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998; 351: 420.
5. Pirzada OM, Taylor CJ. Long term macrolide antibiotics improve pulmonary function in cystic fibrosis. Pediatr Pulmonary 1999; 19 (Suppl): 283.
6. Jaffe A, Bush A. Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonary 2001; 31: 464-473.
7. Tomashefski JF, Abramowsky CR, Dahms BB. The pathology of cystic fibrosis. In: Davis PB, ed. Cystic Fibrosis, New York: Marcel Dekker, 1993: 435-489.
8. Van der Vlite A, Nguyen MN, Shigenaga MK, Eiserich JP, Marelich GP, Cross CE. Myeloperoxidase and protein oxidation in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2000; 279: L537-L546.
9. Lee HS, Majima Y. Quantitative cytology of nasal secretions under various conditions. Laryngoscope 1993; 103: 533-537.
10. Vestwever D, Blanks JE. Mechanisms that regulate the function of the selectines and their ligands. Physiol Rev 1999; 79: 181-213.
11. Hashimoto N, Kawabe T, Hara T, et al. Effect of erythromycin on matrix metalloproteinase-9 and cell migration. J Lab Clin Med 2001; 137: 176-183.
12. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73: 161-195.
13. Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996; 14: 288-295.
14. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997; 17: 519-528.
15. Ito J, Asano K, Tryka E, Kanai K, Yamamoto S, Hisamitsu T, Suzaki H. Suppressive activity of co-stimulatory molecule expressions on mouse splenocytes by anti-allergic agents in vitro. Mediat Inflamm 2000; 9: 69-75.
16. Cataldo DD, Tournoy KG, Vermaelen K, et al. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol 2002; 161: 491-498.
17. Desaki M, Takizawa H, Ohtoshi T, et al. Erythromycin suppresses nuclear factor-κB and activator protein-1 activation in human bronchial epithelial cells. Biochem Biophys Res Commun 2000; 267: 124-128.
18. Tamaoki J, Isono K, Sakai N, Kanemura T, Konno K. Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J 1992; 5: 234-238.
19. Keicho N, Kudoh S, Yotsumoto H, Akagawa K. Antilymphocyic activity of erythromycin distinct from that of FK-506 or cyclosporin A. J Antibiot 1992; 47: 1406-1413.
20. Suzaki H, Asano K, Ohki S, Kanai K, Mizutani T, Hisamitsu T. Suppressive activity of a macrolide antibiotic, roxithromycin, on proinflammatory cytokine production in vitro and in vivo. Mediat Inflamm 1999; 8: 199-204.
21. Asano K, Kamakazu K, Hisamitsu T, Suzaki H. Modulation of Th2 type cytokine production from human peripheral blood leukocytes by a macrolide antibiotic, roxithromycin, in vitro. Int Immunopharmac 2001; 1: 1913-1921.
22. Noma T, Aoki K, Hayashi M, Yoshizaki I, Kawano Y. Effect of roxithromycin on T lymphocyte proliferation and cytokine production elicited by mite antigen. Int Immunopharmac 2001; 1: 201-210.
23. Tirouvanziam R, Khazaal I, Peault B. Primary inflammation in human cystic fibrosis small airways. Am J Physiol Lung Cell Mol Physiol 2002; 283: L445-L451.
24. Al-Rawi MM, Edelstein DR, Erlandson RA. Changes in nasal epithelium in patients with severe chronic sinusitis: a clinicopathologic and electron microscopic study. Laryngoscope 1998; 108: 1816-1823.
25. Majima Y, Masuda S, Sakakura Y. Quantitative study of nasal secretory cells in normal subjects and patients with chronic sinusitis. Laryngoscope 1997; 107: 1515-1518.
26. Atkins JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003; 28: 12-24.
27. Stetler-Stevenson WG. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 1996; 148: 1345-1350.
28. Herouy Y, Mellios P, Bandemir E, Dichmann S, Nockowski P, Schopf E. Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression. J Dermatol Sci 2001; 25: 98-205.
29. Ohno I, Ohtani H, Nitta Y. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997; 16: 212-219.
30. Birkedal-Hansen H, Moore WG, Bodden MK. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250.
31. Cassatella MA. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999; 73: 369-509.
32. Cloutier A, McDonald PP. Transcription factor activation in human neutrophils. In: Cassatella MA, ed. The Neutrophil, Basel: Karger, 2003: 1-23.
33. Wasylyk C, Gutman A, Nicholson R, Wasylyk B. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoprotein. EMBO J 1991; 10: 1127-1134.
34. Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8: 395-405.